Clinical Connection Home
  Welcome To
Clinical Connection
 

Trials
Alerts

Trials
Search

Health
Forum

Health
News

RSS

Intro

Clinics &
Sponsors

Member
Login
View Clinical Trial (Medical Research Study)

Effects of TNF-Alpha Antagonism (Etanercept) in Patients With the Metabolic Syndrome and Psoriasis - NCT00477191-02114 (Clinical Trial 170716)
Permalink: http://www.ClinicalConnection.com/exp/ExpandedPatientViewStudy170716.aspx



** Please review additional "Nearby Studies" on right ----->

Clinical Trials Notification
Clinical Trials Search

City:  Boston
State:  
MA
Zip Code: 02114
Conditions: Psoriasis - Metabolic Syndrome - Hyperlipidemia - Obesity - Hypertension
Purpose: People with psoriasis have significantly higher rates of obesity, diabetes, heart failure and high blood pressure than the general public. The purpose of this study is to determine how substances produced in the fat (inflammatory markers) relate to the risk of heart disease in people with the metabolic syndrome and psoriasis. People with metabolic syndrome have insulin resistance, increased waist size, high blood pressure, or high cholesterol.
Study summary: People with psoriasis have significantly higher rates of obesity, diabetes, heart failure and high blood pressure than the general public. The purpose of this study is to determine how substances produced in the fat (inflammatory markers) relate to the risk of heart disease in people with the metabolic syndrome and psoriasis. People with metabolic syndrome have insulin resistance, increased waist size, high blood pressure, or high cholesterol. Insulin resistance means that the body does not respond well to the insulin in your blood. Therefore, both blood levels of insulin and glucose (sugar) are high. This causes inflammation (irritation) in the body. Inflammation can cause an unhealthy response in your body and blood vessels, and can lead to blockages in the heart and other vessels. TNF-alpha is a substance made by fat and inflammatory cells that helps cause inflammatory reactions. TNF-alpha is thought to be important in causing psoriasis. The drug Etanercept blocks TNF-alpha's actions, and has been approved by the Food and Drug Administration (FDA) for the treatment of psoriasis. We think that Etanercept may also reduce the inflammation associated with metabolic syndrome and decrease the risk of heart disease. People in this study will receive either Etanercept or placebo (contains no active drug).
Criteria: Inclusion Criteria: - hyperinsulinemia - moderate to severe psoriasis - two of the following: obesity, dyslipidemia (high cholesterol), hypertension (high blood pressure) Exclusion Criteria: - On insulin or other diabetes (anti-hyperglycemic) medication - Congestive Heart Failure - Heart Attack, Stroke or Transient Ischemic Attack in last 3 months - Unstable angina - Pulmonary disease requiring oxygen - SLE, optic neuritis, transverse myelitis, epilepsy - Positive PPD - Scheduled for upcoming surgery - Known immunosuppression (for example, HIV) - Known autoimmune disease - Hepatitis B or Hepatitis C - Pregnant or nursing - Renal insufficiency (Creatinine >1.5) - Latex allergy - Use of live vaccination in past 90 days - Organ transplantation - History of severe infection - History of malignancy (except cured non-melanoma skin cancer)
Study is available at: Massachusetts General Hospital
Boston, MA 02114
United States

Primary Contact:
Christina N Alavian, MD
Email: calavian@partners.org
Phone: 617 726-5066
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
Trials Alerts: If you would like to be notified of new clinical trials as they become available please register for a free account.

Data Source: ClinicalTrials.gov
Date Processed: November 16, 2009
Modifications to
this listing:
Only selected fields are shown, please use the link above to view all information about this clinical trial.

 
 
 
 
 
 
 
 












Clinical trials are medical research studies designed to test the safety and/or effectiveness of new drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.


Within 25 Miles

Depression - Boston MA

Depression - Brighton MA

Depression and Anxiety with Insomnia (Females) - Brighton MA

Restless Legs Syndrome - Newton MA



Within 50 Miles

Rheumatoid Arthritis (RA) - West Yarmouth MA

Rheumatoid Arthritis (RA) - Worcester MA

Alzheimer's or Memory Loss Patients Currently Taking Namenda, Aricept, Exelon, or Razadyne - East Providence RI

Depression - Providence RI

Atrial Fibrillation - Cranston RI



Within 100 Miles

Overactive Bladder (Ages 65+) - New London CT

 
Home | Clinical Trials Notification | Search Clinical Trials | About Clinical Trials | Message Board | Investigators
Links | Terms And Conditions | Sitemap | Suggestion/Feedback
© 1998-2009 | All trademarks are property of their legal owners. | All Rights Reserved

ClinicalConnection.com is a resource that provides individuals with information regarding clinical trials that are being conducted nationwide.
ClinicalConnection.com does not conduct these clinical trials nor endorse them. Please consult your doctor or physician before participating.